Home/ Supplements/ Nmn/ NMN 1 g

NMN 1 g

product on market Powder Nutricost Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Nicotinamide Mononucleotide (NMN) serves as a precursor to NAD+, a coenzyme essential for cellular energy metabolism and DNA repair. Current research provides limited evidence regarding its long-term efficacy in humans, though some studies suggest potential improvements in insulin sensitivity. The ingredient is generally considered safe for consumption.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for NMN 1 g
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Gram(s)
Serving Size
50
Servings
Non-Nutrient/Non-Botanical
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 250.0mg (1 products) 6 studies (A:0, B:2)

Other Ingredients

None
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: As a dietary supplement, take 1 scoop daily with 8-12 oz of water or as directed by your healthcare professional.

Warnings & Precautions

Warning: For healthy individuals 18 years and older.

Consult a healthcare professional prior to use if you are pregnant or nursing, taking medication, or have a medical condition.

Keep out of reach of children.

Do not use if safety seal is broken or missing.

Formulation Notes

Nicotinamide Monocleotide 1 g per serving

Additional Information

Notice: Store in a cool, dry place.

Quality Guaranteed Nutricost

Metadata

Product Details

UPC / SKU8 10014 67334 9
DSLD Entry Date2022-06-16
Product TypeNon-Nutrient/Non-Botanical
FormPowder
DSLD ID270614
Data Updated2026-04-11
Research

Research Evidence

8
Research Sources
54
Avg Quality
4
Rct
2
Meta Analysis
2
Clinical Trial
B Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials
Meta Analysis Critical reviews in food science and nutrition 2025 PubMed DOI
B Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study
Rct GeroScience 2024 PubMed DOI
C Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women.
Rct Science (New York, N.Y.) PubMed DOI
C The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial.
Rct GeroScience PubMed DOI
C Effects of Nicotinamide Mononucleotide on Glucose and Lipid Metabolism in Adults: A Systematic Review and Meta-analysis of Randomised Controlled Trials
Meta Analysis Current diabetes reports 2024 PubMed DOI
C Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial
Rct Scientific reports 2023 PubMed DOI
C Safety and Pharmacokinetics of Nicotinamide Mononucleotide (NMN) in Healthy Adults.
Clinical Trial ClinicalTrials.gov 2021
C Effect of 'Nicotinamide Mononucleotide' (NMN) on Cardiometabolic Function
Clinical Trial ClinicalTrials.gov 2017
View all evidence for Nmn →
Compare

Similar Products

View all Nmn products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.